Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 3ZE3E | — |
administered only the diluent sterile water) without mixing with the powder (lyophilized part) of Priorix; administered only the diluent sterile water) without mixing with the powder (lyophilized part) of Priorix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 54-year-old female patient who received MMR (Priorix) (batch number 3ZE3E, expiry date 22-NOV-2028) for prophylaxis. On 17-MAR-2025, the patient received Priorix. On 17-MAR-2025, an unknown time after receiving Priorix, the patient experienced inappropriate dose of vaccine administered (Verbatim: administered only the diluent sterile water) without mixing with the powder (lyophilized part) of Priorix) and inappropriate preparation of medication (Verbatim: administered only the diluent sterile water) without mixing with the powder (lyophilized part) of Priorix). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 19-MAR-2025 The reporter reported that the patient was administered only the diluent (sterile water) without mixing with the powder (lyophilized part) of Priorix which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. Can it be diluted with other sterile water? The vaccine administration facility is the same as primary reporter.; Sender's Comments: US-GSK-US2025033667:Same reporter/Different patient